Document is current
Any future updates will be listed below
-
Authors
Varga, Balazs R.
Bernhard, Sarah M. https://orcid.org/0000-0001-8549-0413
El Daibani, Amal
Zaidi, Saheem A.
Lam, Jordy H. https://orcid.org/0000-0002-5496-6228
Aguilar, Jhoan https://orcid.org/0000-0003-0918-3440
Appourchaux, Kevin https://orcid.org/0000-0001-9853-3347
Nazarova, Antonina L.
Kouvelis, Alexa
Shinouchi, Ryosuke
Hammond, Haylee R.
Eans, Shainnel O.
Weinreb, Violetta
Margolis, Elyssa B. https://orcid.org/0000-0001-8777-302X
Fay, Jonathan F. https://orcid.org/0000-0003-1822-2384
Huang, Xi-Ping
Pradhan, Amynah https://orcid.org/0000-0001-9691-2976
Katritch, Vsevolod https://orcid.org/0000-0003-3883-4505
McLaughlin, Jay P. https://orcid.org/0000-0001-9851-9342
Majumdar, Susruta https://orcid.org/0000-0002-2931-3823
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RO1DA057790)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM153437)
- License Information
-
More Information
Article History
Received: 30 June 2024
Accepted: 28 February 2025
First Online: 13 March 2025
Competing interests
: S.M. is a cofounder of Sparian biosciences. S.M., V.K., S.A.Z., T.C., J.P.M., and B.R.V. have filed patents on delta opioid bitopics developed in this manuscript. The remaining authors declare no competing interests.
